期刊文献+

来曲唑治疗妇科内分泌疾病患者的疗效观察研究 被引量:1

下载PDF
导出
摘要 目的分析妇科内分泌疾病患者采取来曲唑治疗的临床疗效。方法选取2016年5月~2018年5月入本院实施治疗的妇科内分泌疾病患者100例进行研究,按照随机双盲法分为观察组与对照组,每组50例患者。对照组按照米非司酮方案用药治疗,观察组按照来曲唑方案用药治疗。评价两组效果,记录不良反应,测定治疗前后血清E2水平,并比较分析。结果两组患者均有不良反应,但组间对比无显著差异(P> 0.05);观察组总有效率显著高于对照组,差异有统计学意义(P <0.05);两组患者治疗前血清E2无显著差异(P> 0.05),治疗后两组均有改善,但观察组治疗后优于对照组,差异有统计学意义(P <0.05)。结论来曲唑应用在妇科内分泌疾病中可取得良好的效果,一方面可提高总有效率,另一方面安全性高,且能更好地改善血清E2指标,值得应用。
作者 刘建英
出处 《临床研究》 2019年第5期100-101,共2页 Clinical Research
  • 相关文献

参考文献8

二级参考文献72

  • 1Corona G, Rastrelli G, Vignozzi L, et al. Emerging medication for thetreatment of male hypogonadism [ J ]. Expert Opin Emerg Drugs, 20 l 2, 17(2) :239-259.
  • 2Hayes FJ, Seminara SB, Decruz S, et al. Aro~natase inhibition in the human male reveals a hypothalamic site of estrogen feedback [ J 1. J Clin Endocrinol Metab, 2000,85 ( 9 ) :3027-3035.
  • 3Pitteloud N, Dwyer AA, Decruz S, et al. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men [ J ]. J Clin Endocrinol Metab, 2008,93 (3) :784-791.
  • 4Holbrook JM, Cohen PG. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation [ J ]. South Med J, 2003,96 ( 6 ) : 544-547.
  • 5Bouvattier C, Maione L, Bouligand J, et al. Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism [J]. Nat Rev Endocrinol, 2012,8(3 ) : 172-182.
  • 6Hadziselimovic NO, de Geyter C, Demougin P, et al. Decreased expression of FGFRI, SOS1. RAF1 genes in cryptorchidism[J]. Urol Int, 2010,84(3 ) :353-36l.
  • 7Cotton L, Gibbs GM, Sanchez-Partida LG, et al. FGFR-I [ corrected] signaling is involved in spermiogenesis and sperm capacitation [ J ]. J Cell Sci, 2006,119( 1 ) :75-84.
  • 8Nishio H, Mizuno K, Moritoki Y, et al. Clinical features and testicular morphology in patients with Kallmann syndrome [ J ]. Urology, 2012,79 (3) :684-686.
  • 9Salenave S, Chanson P, Bry H, et al. Kalhnann' s syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations [ J ]. J Clin Endocrinol Metab, 2008,93 ( 3 ) : 758-763.
  • 10Saylam B, Efesoy O, Cayan S. The effect of aronmtase inhibitor letrozole on body mass index, serum hormones, and sperm paramete~ in infertile men[J]. Fertil Steril, 2011,95(2) :809-811.

共引文献273

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部